Spinal Cord Injury clinical trials at UC Irvine
2 in progress, 1 open to eligible people
Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder
open to eligible people ages 18-70
The purpose of this study is to evaluate the effectiveness and safety of SCONE neuromodulation therapy after 12 weeks of therapy in comparison to inactive sham control in improving symptoms of Neurogenic Lower Urinary Tract Dysfunction
Downey, California and other locations
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
Sorry, not currently recruiting here
The purpose of this study is to compare the efficacy and safety of intravenous (IV) infusions of MT-3921 to placebo in subjects with acute traumatic cervical spinal cord injury. Subjects meeting eligibility criteria will enter the 6-month double-blind period. Subjects will be randomized in a 2:1 ratio to receive MT-3921 or placebo in a double blind manner.
Orange, California and other locations
Last updated: